[Recurrence of bacterial endophthalmitis after penetrating keratoplasty].
OBJECTIVE
One month after penetrating keratoplasty, a male patient suffered recurrent abscess and endophthalmitis caused by mixed bacteria (Staphylococcus aureus and Candida Albicans).


RESULTS
Two samples of vitreous and aqueous were taken, and a combination of systemic Vancomycin and Amphotericin B were injected intravitreally. The patient was asymptomatic for a month, but the abscess reactivated and was treated with Vancomycin and Ciprofloxacin administered intravenously. Fifteen days after withdrawing the treatment endophthalmitis returned and was treated with vitrectomy and additional systemic/intravitreal antibiotics and antifungal therapy. The final visual acuity was 20/40.


CONCLUSIONS
The delayed vitrectomy proved to be necessary to remove established germs and to eliminate recurrent infections.
García Serrano
J L
JL
Servicio de Oftalmología, Hospital Universitario de Granada, Spain. dc09sv6a@teleline.es
Domínguez
I
I
Serrano Laborda
D
D
D000038:Abscess / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D001082:Aqueous Humor / Q000382:microbiology; D002176:Candida albicans / Q000302:isolation & purification; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D015948:Keratoplasty, Penetrating; D008297:Male; D011183:Postoperative Complications; D012008:Recurrence; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000302:isolation & purification; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use; D014822:Vitreous Body / Q000382:microbiology
D002939:Ciprofloxacin; D014640:Vancomycin; D000666:Amphotericin B